Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
96.73
Dollar change
+0.85
Percentage change
0.89
%
Index- P/E13.54 EPS (ttm)7.14 Insider Own0.00% Shs Outstand2.04B Perf Week0.68%
Market Cap189.25B Forward P/E12.49 EPS next Y7.74 Insider Trans- Shs Float1.96B Perf Month-5.37%
Income14.85B PEG2.03 EPS next Q1.67 Inst Own7.28% Short Float0.21% Perf Quarter-2.99%
Sales49.78B P/S3.80 EPS this Y9.45% Inst Trans-9.09% Short Ratio2.89 Perf Half Y1.96%
Book/sh22.83 P/B4.24 EPS next Y9.35% ROA7.76% Short Interest4.15M Perf Year12.39%
Cash/sh7.37 P/C13.12 EPS next 5Y6.68% ROE16.52% 52W Range84.94 - 108.78 Perf YTD-4.20%
Dividend Est.3.66 (3.78%) P/FCF14.13 EPS past 5Y5.63% ROI22.26% 52W High-11.08% Beta0.54
Dividend TTM3.78 (3.90%) Quick Ratio0.93 Sales past 5Y0.78% Gross Margin70.87% 52W Low13.88% ATR (14)1.09
Dividend Ex-DateMar 07, 2024 Current Ratio1.16 EPS Y/Y TTM125.94% Oper. Margin26.06% RSI (14)39.18 Volatility0.66% 0.88%
Employees76057 Debt/Eq0.56 Sales Y/Y TTM-1.51% Profit Margin29.83% Recom2.52 Target Price110.57
Option/ShortYes / Yes LT Debt/Eq0.43 EPS Q/Q502.21% Payout44.73% Rel Volume1.06 Prev Close95.88
Sales Surprise-3.88% EPS Surprise-7.31% Sales Q/Q-9.98% EarningsJan 31 BMO Avg Volume1.43M Price96.73
SMA20-1.97% SMA50-5.10% SMA200-1.33% Trades Volume1,524,598 Change0.89%
Date Action Analyst Rating Change Price Target Change
Feb-23-24Initiated BMO Capital Markets Market Perform $114
Jan-23-24Initiated Morgan Stanley Equal-Weight $114
Jan-16-24Resumed UBS Buy
Dec-18-23Downgrade HSBC Securities Buy → Hold
Sep-25-23Upgrade Morgan Stanley Underweight → Equal-Weight
Jul-14-23Initiated HSBC Securities Buy
Apr-26-23Upgrade Deutsche Bank Hold → Buy
Mar-27-23Upgrade Deutsche Bank Sell → Hold
Jan-26-23Downgrade Citigroup Buy → Neutral
Dec-05-22Upgrade Stifel Hold → Buy
Today 09:00AM
Mar-27-24 06:00PM
Mar-26-24 07:49AM
06:18AM
Mar-25-24 06:15PM
12:58PM Loading…
12:58PM
07:26AM
Mar-24-24 10:40AM
08:15AM
Mar-22-24 07:22AM
Mar-19-24 06:00PM
Mar-18-24 06:15PM
01:28PM
Mar-17-24 08:50AM
Mar-15-24 10:37AM
09:38AM Loading…
Mar-14-24 09:38AM
09:00AM
08:45AM
Mar-13-24 09:02AM
07:08AM
Mar-12-24 06:00PM
Mar-11-24 06:15PM
12:44PM
Mar-10-24 06:35AM
Mar-06-24 05:01AM
Mar-05-24 06:00PM
09:22AM
02:56AM
Mar-04-24 01:15AM
Mar-01-24 03:10PM
09:00AM Loading…
09:00AM
Feb-29-24 08:30AM
Feb-28-24 06:00PM
10:27AM
Feb-27-24 08:00AM
Feb-23-24 05:43AM
Feb-22-24 09:21AM
Feb-15-24 04:13PM
Feb-14-24 03:21PM
08:00AM
Feb-10-24 08:30AM
Feb-06-24 11:16AM
10:29AM
04:30AM
04:23AM
01:40AM
Feb-05-24 06:54PM
06:47PM
06:35PM
05:44PM
05:30PM
04:55PM
04:52PM
04:45PM
Feb-04-24 05:50AM
Feb-02-24 08:52AM
Feb-01-24 01:23PM
11:55AM
Jan-31-24 04:05PM
03:56PM
02:30PM
01:50PM
12:50PM
11:47AM
11:00AM
10:48AM
09:30AM
09:09AM
05:17AM
05:14AM
05:08AM
03:40AM
01:58AM
01:16AM
01:00AM
Jan-30-24 06:24PM
07:59AM
Jan-29-24 11:00PM
02:03PM
Jan-26-24 09:15AM
Jan-24-24 11:39AM
04:27AM
Jan-22-24 08:34PM
08:11PM
06:00PM
07:00AM
Jan-19-24 04:43PM
10:00AM
07:09AM
Jan-18-24 06:15PM
12:11PM
Jan-17-24 05:07PM
10:15AM
Jan-16-24 07:43AM
Jan-12-24 06:00PM
06:09AM
05:27AM
Jan-11-24 06:15PM
04:22PM
04:05PM
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.